Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 1 de 1
Filtrar
Mais filtros

Bases de dados
Ano de publicação
Tipo de documento
País de afiliação
Intervalo de ano de publicação
1.
Stat Methods Med Res ; 25(1): 153-66, 2016 Feb.
Artigo em Inglês | MEDLINE | ID: mdl-22504231

RESUMO

The statistical analysis of continuous longitudinal data may be complicated since quantitative levels of bioassay cannot always be determined. Values beyond the limits of detection (LOD) in the assays may not be observed and thus censored, rendering complexity to the analysis of such data. This article examines how both left-censoring and right censoring of HIV-1 plasma RNA measurements, collected for the study on AIDS-related Non-Hodgkin's lymphoma (AR-NHL) in East Africa, affects the quantification of viral load and explores the natural history of viral load measurements over time in AR-NHL patients receiving anticancer chemotherapy. Data analyses using Monte Carlo EM algorithm (MCEM) are compared to analyses where the LOD or LOD/2 (left censoring) value is substituted for the censored observations, and also to other methods such as multiple imputation, and maximum likelihood estimation for censored data (generalized Tobit regression). Simulations are used to explore the sensitivity of the results to changes in the model parameters. In conclusion, the antiretroviral treatment was associated with a significant decrease in viral load after controlling the effects of other covariates. A simulation study with finite sample size shows MCEM is the least biased method and the estimates are least sensitive to the censoring mechanism.


Assuntos
Interpretação Estatística de Dados , Limite de Detecção , Modelos Estatísticos , Algoritmos , Bioestatística , Ensaios Clínicos como Assunto , Simulação por Computador , HIV-1 , Humanos , Modelos Lineares , Estudos Longitudinais , Linfoma Relacionado a AIDS/tratamento farmacológico , Linfoma Relacionado a AIDS/virologia , Linfoma não Hodgkin/tratamento farmacológico , Linfoma não Hodgkin/virologia , Método de Monte Carlo , RNA Viral/sangue , Carga Viral/efeitos dos fármacos
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA